We produce drugs that effectively treat diseases and infections.
Amponsah-Efah Pharmaceuticals Limited, also known as A-EFAH Pharmaceuticals Limited is a dynamic Ghanaian private limited liability company operating in Fumesua in the Ejisu Juaben Municipality of the Ashanti Region of Ghana, West Africa.
The company began in 1985 as a pharmacy shop, and has grown steadily into pharmaceutical manufacturing.Read More
We are a pharmaceutical company dedicated to helping people everywhere, fight their diseases and maintain their health, by providing them with effective pharmaceutical products.
To Develop into and Endure as a Leading Worldwide Pharmaceutical Manufacturing Company
The company has installed a capacity of 2billion tablets per annum shift. It also has a modern oral liquids manufacturing plant with a capacity of 12 million bottles per annum per shift.
Meet our leaders and the hard-working personalities who deliver innovative concepts and also able to guide staff to reach goal.
We have available positions in various departments within our organisation.View Available Positions
The Company has a well equipped Formulation and Development department which is well resourced with pharmacists, scientists and supporting staff, to deliver on its mandate of supplying the Company with a regular stream of registered new products.
We are proud to unveil our 1.140MWP solar farm project to the public. This solar farm project was aimed at providing alternative energy for the national grid and it has really served as an efficient source of energy here at our factory.
The project came in after we installed a new heating, ventilation and air conditioning (HVAC) system in our factory, which increased our energy requirements by more than three times.
“I am thankful to the REDAVIA team for the tenacity and professionalism they showed leading a safe, successful installation and implementation,” said Mr. K. Amponsah-Efah, Managing Director of Amponsah Efah Pharmaceuticals. “I am looking forward to a good business relationship for years to come.”